Liver metastases from colorectal cancer: radioembolization with systemic therapy.

Liver metastases from colorectal cancer: radioembolization with systemic therapy.

The majority of patients with advanced colorectal cancer die from hepatic metastases caused by disease progression; therefore, several novel technologies are in clinical development to potentially improve local control of liver disease. Radioembolization is a technique for administering radiotherapy...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Nicolay, N, Berry, D, Sharma, R
Formato:	Journal article
Idioma:	English
Publicado em:	2009

Registros relacionados

Author reply: Radioembolization for colorectal liver metastases
por: Nicolay, N, et al.
Publicado em: (2010)

Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.
por: Sharma, R, et al.
Publicado em: (2007)

Regional Hepatic Chemotherapies in the Treatment of Colorectal Cancer Metastases to the Liver
por: Pwint, T, et al.
Publicado em: (2010)

Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liver.
por: Pwint, T, et al.
Publicado em: (2010)

Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases
por: Rahbari, N. N., et al.
Publicado em: (2018)

Hepatic artery chemotherapy and colorectal liver metastases.
por: Brooks, A, et al.
Publicado em: (2003)

Dosimetric analysis of individual liver metastases from colorectal cancer following 90 y microsphere selective internal radiation therapy
por: Abbott, E, et al.
Publicado em: (2017)

Hepatic artery chemotherapy and colorectal liver metastases - Reply
por: Kerr, D, et al.
Publicado em: (2003)

Hepatic arterial chemotherapy for colorectal cancer liver metastases: a review of advances in 2003.
por: Chan, R, et al.
Publicado em: (2004)

Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.
por: Stessels, F, et al.
Publicado em: (2004)

Colorectal cancer liver metastases organoids retain characteristics of original tumor and acquire chemotherapy resistance
por: Buzzelli, J, et al.
Publicado em: (2018)

Research reporting standards for radioembolization of hepatic malignancies.
por: Salem, R, et al.
Publicado em: (2011)

Myofibroblast activation in colorectal cancer lymph node metastases.
por: Yeung, T, et al.
Publicado em: (2013)

Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
por: Lyon, P, et al.
Publicado em: (2018)

FOXFIRE: a phase III clinical trial of chemo-radio-embolisation as first-line treatment of liver metastases in patients with colorectal cancer.
por: Sharma, R, et al.
Publicado em: (2008)

Clinical benefit and potential pitfalls in combining thermal ablation and radiation therapy to treat liver metastases.
por: Sharma, R, et al.
Publicado em: (2013)

Hepatic resection following selective internal radiation therapy for colorectal cancer metastases in the FOXFIRE clinical trial: clinical outcomes and distribution of microspheres
por: Winter, H, et al.
Publicado em: (2019)

Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.
por: Kerr, D, et al.
Publicado em: (2003)

Quality of life in patients with liver metastases from colorectal cancer treated with first-line selective internal radiotherapy (SIRT): Results from the FOXFIRE prospective randomized studies
por: Gray, A, et al.
Publicado em: (2017)

Stereotactic body radiotherapy for liver metastases.
por: Aitken, K, et al.
Publicado em: (2015)

Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases
por: Wang, L, et al.
Publicado em: (2013)

WHAT IS THE TRUE INCIDENCE OF METACHRONOUS COLORECTAL LIVER METASTASES? EVIDENCE FROM THE UK FACS (FOLLOW-UP AFTER COLORECTAL SURGERY) TRIAL (ISRCTN: 41458548)
por: Pugh, S, et al.
Publicado em: (2012)

Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases.
por: Wang, L, et al.
Publicado em: (2013)

Selective Internal Radiotherapy (SIRT) in metastatic colorectal cancer patients with liver metastases: Preliminary primary care resource use and utility results from the Foxfire randomised controlled trial
por: Fusco, R, et al.
Publicado em: (2017)

Monitoring circulating tumour DNA in patients receiving selective internal radiation therapy for liver metastases and intrahepatic cholangiocarcinoma
por: Winter, H, et al.
Publicado em: (2016)

Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver
por: Naba, Alexandra, et al.
Publicado em: (2014)

Overall survival analysis of the FOXFIRE prospective randomized studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer
por: Virdee, P
Publicado em: (2017)

FOXFIRE-SIRFLOX-FOXFIRE global prospective randomised studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer: KRAS mutation and tumour site analysis
por: Wasan, H, et al.
Publicado em: (2017)

O-027: Overall survival analysis of the FOXFIRE-SIRFLOX-FOXFIRE global prospective randomized studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer
por: Wasan, H, et al.
Publicado em: (2017)

Adjuvant therapy of colorectal cancer.
por: Midgley, R, et al.
Publicado em: (2000)

Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
por: Rockall, A, et al.
Publicado em: (2009)

Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases
por: Yuzhalin, A, et al.
Publicado em: (2019)

Bilious pleuritis following transpulmonary radiofrequency ablation of liver metastases
por: Kalin, A, et al.
Publicado em: (2017)

Quality of life in patients with liver metastases from colorectal cancer treated with first-line selective internal radiotherapy (SIRT): EQ-5D, EORTC QLQ-C30 and LMC21 results from the FOXFIRE study
por: Wolstenholme, J, et al.
Publicado em: (2017)

Gene therapy for colorectal cancer.
por: Kerr, D, et al.
Publicado em: (2003)

ABC of colorectal cancer: adjuvant therapy.
por: Midgley, R, et al.
Publicado em: (2000)

Evolution of nonsurgical therapy for colorectal cancer.
por: Midgley, R, et al.
Publicado em: (2009)

Outcome of liver resection for small bowel neuroendocrine tumour metastases
por: Polkinghorne, MD, et al.
Publicado em: (2018)

The interaction between the Hypoxia Inducible Factor-1Α (HIF-1Α) and ERBB signalling pathways in colorectal liver metastases (CRLM)
por: Siriwardana, PN, et al.
Publicado em: (2016)

Targeting docetaxel-PLA nanoparticles simultaneously inhibit tumor growth and liver metastases of small cell lung cancer
por: Liang, Z, et al.
Publicado em: (2015)